ISOPP 2019 Interview: Choosing cancer clinical trial endpoints


Date posted:
October 2019
Date resource created:
October 10, 2019
Symposium: Fundamental
Content Type:
Symposium (International)
File type:
Video (Interview)
Bruce Burnett

Bruce Burnett, Swansea University, Swansea, UK, highlights the important considerations when choosing cancer clinical trial endpoints. This interview took place at the International Society of Oncology Pharmacy Practitioners (ISOPP) Symposium 2019, hosted by the British Oncology Pharmacy Association (BOPA), held in London, UK.